Menu Search

Switzerland

SPI Large Company IndexLast 5 days
Last price19,679.86
SPI Medium Company IndexLast 5 days
Last price25,423.85
SPI Small Company IndexLast 5 days
Last price32,769.54
Swiss All-Share IndexLast 5 days
Last price876.19
SMILast 5 days
Last price14,223.90

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.9337
GBP		-0.0002 / -0.03%0.0156 / 1.70%
Today
0.9097Jun 30 20250.9713Mar 02 2026
CHFEUR1.08
EUR		-0.0002 / -0.02%0.0141 / 1.32%
Today
1.06Aug 18 20251.11Mar 09 2026
CHFUSD1.24
USD		-0.0009 / -0.07%-0.0236 / -1.88%
Today
1.22Aug 01 20251.31Jan 27 2026
CHFJPY200.40
JPY		-0.115 / -0.06%18.78 / 10.34%
Today
180.10Jun 30 2025204.42Apr 21 2026
CHFAUD1.80
AUD		0.0019 / 0.11%-0.1164 / -6.07%
Today
1.76May 13 20261.97Oct 17 2025
CHFCAD1.76
CAD		-0.0003 / -0.02%0.0431 / 2.51%
Today
1.69Aug 12 20251.79Jan 27 2026
CHFCNY8.41
CNY		-0.0041 / -0.05%-0.6254 / -6.92%
Today
8.35Jun 25 20269.14Jan 27 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
SHL Telemedicine LtdSHLTN:SWX1.04
CHF		+0.13
+14.29%		533.10k
EvoNext Holdings SAEVE:SWX2.72
CHF		+0.32
+13.33%		77.80k
SMG Swiss Marketplace Group Holding AGSMG:SWX24.90
CHF		+1.40
+5.96%		219.08k
DocMorris AGDOCM:SWX8.79
CHF		+0.49
+5.90%		809.94k
Lem Holding SALEHN:SWX471.00
CHF		+23.50
+5.25%		2.14k
OC Oerlikon Corporation AG, PfaeffikonOERL:SWX4.09
CHF		+0.17
+4.34%		800.49k
Galderma Group AGGALD:SWX185.80
CHF		+7.55
+4.24%		498.07k
Kuros Biosciences AGKURN:SWX18.96
CHF		+0.68
+3.72%		154.08k
R&S Group Holding AGRSGN:SWX26.66
CHF		+0.90
+3.49%		169.98k
Medartis Holding AGMED:SWX82.80
CHF		+2.40
+2.99%		3.12k
Data delayed at least 15 minutes, as of Jun 29 2026 16:31 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.